• 1
    Denburg JA, Telizyn S, Belda A, Dolovich J, Bienenstock J. Increased numbers of circulating basophil progenitors in atopic patients. J Allergy Clin Immunol 1985; 76:46672.
  • 2
    Sehmi R, Howie K, Sutherland DR, Schragge W, O'Byrne PM, Denburg JA. Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects. Am J Respir Cell Mol Biol 1996; 15:64555.
  • 3
    Gibson PG, Dolovich J, Girgis-Gabardo A et al. The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors. Clin Exp Allergy 1990; 20:6618.
  • 4
    Gibson PG, Manning PJ, O'Byrne PM et al. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors. Am Rev Respir Dis 1991; 143:3315.
  • 5
    Sehmi R, Wood LJ, Watson R et al. Allergen-induced increases in IL-5 receptor α-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 1997; 100:246675.
  • 6
    Denburg JA, Sehmi R, Upham J, Wood L, Gauvreau G, O'Byrne P. Regulation of IL-5 and IL-5 receptor expression in the bone marrow of allergic asthmatics. Int Arch Allergy Immunol 1999; 118:1013.
  • 7
    Robinson DS, Damia R, Zeibecoglou K et al. CD34+/interleukin-5Rα messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors. Am J Respir Cell Mol Biol 1999; 20:913.
  • 8
    Cameron L, Christodoulopoulos P, Lavigne F et al. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor. J Immunol 2000; 164:153845.
  • 9
    Fanat AI, Thomson JV, Radford K, Nair P, Sehmi R. Human airway smooth muscle promotes eosinophil differentiation. Clin Exp Allergy 2009; 39:100917.
  • 10
    Chihara J, Plumas J, Gruart V et al. Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor. J Exp Med 1990; 172:134751.
  • 11
    Hogan SP, Rosenberg HF, Moqbel R et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008; 38:70950.
  • 12
    Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003; 167:199204.
  • 13
    Nair P, Pizzichini MM, Kjarsgaard M et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360:98593.
  • 14
    Kolbeck R, Kozhich A, Humbles A et al. MEDI-563, a humanized anti-IL-5Ra antibody with enhanced effector function, induces reversible blood eosinopenia in mild asthmatics [abstract]. J Allergy Clin Immunol 2008; 00:S47.
  • 15
    Imaoka H, Babirad I, Kwon Y et al. Increase in sputum levels of vascular endothelial progenitor cells in asthmatic subjects following allergen challenge [abstract]. Eur Respir J 2010; 36:86s.
  • 16
    Belvisi MG, Hele DJ, Birrell MA. Peroxisome proliferator-activated receptor γ agonists as therapy for chronic airway inflammation. Eur J Pharmacol 2006; 533:1019.
  • 17
    Spears M, McSharry C, Thomson NC. Peroxisome proliferator-activated receptor-γ agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 2006; 36:1494504.
  • 18
    Kota BP, Huang TH, Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res 2005; 51:8594.
  • 19
    Trifilieff A, Bench A, Hanley M, Bayley D, Campbell E, Whittaker P. PPAR-α and -γ but not -δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-κB-independent effect. Br J Pharmacol 2003; 139:16371.
  • 20
    Smith SG, Imaoka H, Punia N et al. The effect of PPAR agonists on the migration of mature and immature eosinophils. PPAR Research 2012; 2012:18.
  • 21
    Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR γ2, a lipid-activated transcription factor. Cell 1994; 79:114756.
  • 22
    Yanase T, Yashiro T, Takitani K et al. Differential expression of PPAR γ1 and γ2 isoforms in human adipose tissue. Biochem Biophys Res Commun 1997; 233:3204.
  • 23
    Greene ME, Blumberg B, McBride OW et al. Isolation of the human peroxisome proliferator activated receptor γ cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 1995; 4:28199.
  • 24
    Hirase N, Yanase T, Mu Y et al. Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562. Leuk Res 2000; 24:393400.
  • 25
    Zang C, Liu H, Posch MG et al. Peroxisome proliferator-activated receptor γ ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia. Leuk Res 2004; 28:38797.
  • 26
    Deldar A, Williams G, Stevens C. Pathogenesis of thiazolidinedione induced hematotoxicity in the dog, Diabetes (Suppl) 1993; 42:179.
  • 27
    Nagasawa E, Abe Y, Nishimura J, Yanase T, Nawata H, Muta K. Pivotal role of peroxisome proliferator-activated receptor γ (PPARγ) in regulation of erythroid progenitor cell proliferation and differentiation. Exp Hematol 2005; 33:85764.
  • 28
    Bernardo A, Bianchi D, Magnaghi V, Minghetti L. Peroxisome proliferator-activated receptor-γ agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. J Neuropathol Exp Neurol 2009; 68:797808.
  • 29
    Rosen ED, Spiegelman BM. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001; 276:377314.
  • 30
    Stafford S, Lowell C, Sur S, Alam R. Lyn tyrosine kinase is important for IL-5-stimulated eosinophil differentiation. J Immunol 2002; 168:197883.
  • 31
    Pazdrak K, Olszewska-Pazdrak B, Stafford S, Garofalo RP, Alam R. Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J Exp Med 1998; 188:4219.
  • 32
    Adachi T, Choudhury BK, Stafford S, Sur S, Alam R. The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions. J Immunol 2000; 165:2198204.
  • 33
    Caldenhoven E, van Dijk TB, Tijmensen A et al. Differential activation of functionally distinct STAT5 proteins by IL-5 and GM-CSF during eosinophil and neutrophil differentiation from human CD34+ hematopoietic stem cells. Stem Cells 1998; 16:397403.
  • 34
    Denburg JA, Richardson M, Telizyn S, Bienenstock J. Basophil/mast cell precursors in human peripheral blood. Blood 1983; 61:77580.
  • 35
    Denburg JA, Woolley M, Leber B, Linden M, O'Byrne P. Basophil and eosinophil differentiation in allergic reactions. J Allergy Clin Immunol 1994; 94:113541.
  • 36
    Lamkhioued B, Abdelilah SG, Hamid Q, Mansour N, Delespesse G, Renzi PM. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells. J Immunol 2003; 170:53747.
  • 37
    Lu L, Walker D, Broxmeyer HE, Hoffman R, Hu W, Walker E. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies. J Immunol 1987; 139:18239.
  • 38
    Stirling RG, van Rensen EL, Barnes PJ, Chung KF. Interleukin-5 induces CD34+ eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med 2001; 164:14039.
  • 39
    Menzies-Gow AN, Flood-Page PT, Robinson DS, Kay AB. Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non-asthmatic volunteers. Clin Exp Allergy 2007; 37:102332.
  • 40
    Menzies-Gow A, Flood-Page P, Sehmi R et al. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 2003; 111:7149.
  • 41
    Dorman SC, Efthimiadis A, Babirad I et al. Sputum CD34+ IL-5Rα+ cells increase after allergen: evidence for in situ eosinophilopoiesis. Am J Respir Crit Care Med 2004; 169:5737.
  • 42
    Chou CL, Wang CH, Kuo HP. Upregulation of IL-5 receptor expression on bone marrow-derived CD34+ cells from patients with asthma. Changgeng Yi Xue Za Zhi 1999; 22:41622.
  • 43
    Wood LJ, Inman MD, Watson RM, Foley R, Denburg JA, O'Byrne PM. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1998; 157:99105.
  • 44
    Gauvreau GM, Wood LJ, Sehmi R et al. The effects of inhaled budesonide on circulating eosinophil progenitors and their expression of cytokines after allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med 2000; 162:213944.
  • 45
    Cyr MM, Baatjes AJ, Dorman SC et al. In vitro effects of budesonide on eosinophil–basophil lineage commitment. Open Respir Med J 2008; 2:606.
  • 46
    Elsas PX, Neto HA, Cheraim AB et al. Induction of bone-marrow eosinophilia in mice submitted to surgery is dependent on stress-induced secretion of glucocorticoids. Br J Pharmacol 2004; 143:5418.
  • 47
    Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998; 74:49139.
  • 48
    Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9:1806.
  • 49
    Malmstrom K, Carafoli E. The effect of Ca2+ on the oxidation of β-hydroxybutyric acid by heart mitochondria. Biochem Biophys Res Commun 1976; 69:65864.
  • 50
    Raingeaud J, Gupta S, Rogers JS et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270:74206.
  • 51
    Foltz IN, Schrader JW. Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 1997; 89:30926.
  • 52
    Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J Exp Med 1995; 181:182734.
  • 53
    Bracke M, Coffer PJ, Lammers JW, Koenderman L. Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils. J Immunol 1998; 161:676874.